| OBJECTIVE: The objective is to study the efficacy and safety of multimodal blood management in the primary revision of hip joint.METHODS: A total of 27 patients underwent Hip revision surgery under general anesthesia from January 2015 to July 2017,13 patients with multimodal blood management were enrolled in the study group,and 14 of the untreated control group were analyzed.The difference of age,sex and body mass index between the two groups was compared between the experimental group and the control group.The hemoglobin,operation time and intraoperative blood loss,postoperative 2d hemoglobin,perioperative blood transfusion,postoperative drainage and deep venous thrombosis,pulmonary embolism and other postoperative complications were compared between the two groups.Results: There was no significant difference in age,sex and body mass index between the experimental group and the control group(P> 0.05).There was no significant difference of hemoglobin between the experimental group(12.5.5 ± 7.28 g / L)and the control group(124.6 ±11.12 g / L)(P = 0.179).The operative time(121.2 ± 15.11min)(P <0.05).There was no statistically significant difference of operative time between the experimental group(121.2 ± 15.11 min)and the control group(124.3 ±12.72 min)(P = 0.549).There were significantly different(P <0.05)between intraoperative blood loss(356.9 ± 64.86),postoperative drainage(76.9 ± 14.89),2d hemoglobin(97.7 ± 8.89),postoperative blood transfusion(46.2 ± 119.83)in the experimental group and intraoperative blood loss(455.0 ± 146.27),postoperative drainage(99.8 ± 31.10),2 days after hemoglobin(86.1 ± 15.70),postoperative blood transfusion(257.1 ±308.13)in the control group.But there was no significant difference in the incidence of complications between the two groups(P> 0.05).Conclusion: Multimodal blood management can effectively reduce intraoperative blood loss,postoperative drainage,postoperative blood transfusion,and no side effects in safety. |
PDF Full Text Request